PRAME and sarcoma: PRAME positivity in CIC::DUX4 sarcomas has not been documented in the current medical literature; we hope that it will serve as a useful diagnostic tool in the workup of these challenging tumors and may further assist our understanding of their underlying pathogenesis. More cases are needed to further evaluate the utility of the PRAME immunostain in undifferentiated round cell soft tissue sarcomas.